(Q44208966)

30 November 2017

Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor: a 24-week controlled trial (English)

1 reference

30 November 2017

diabetic polyneuropathy

1 reference

J Fagius

1

1 reference

30 November 2017

A Brattberg

series ordinal

2

1 reference

30 November 2017

S Jameson

series ordinal

3

1 reference

30 November 2017

C Berne

series ordinal

4

1 reference

30 November 2017

language of work or name

1 reference

1 June 1985

1 reference

30 November 2017

1 reference

30 November 2017

28

1 reference

30 November 2017

6

1 reference

30 November 2017

323-329

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00283137

30 November 2017

0 references

cites work

Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man.

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)

1 reference

12 December 2020

Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

1 reference

12 December 2020

Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy

1 reference

12 December 2020

A rapid microchromatographic method for determination of hemoglobin AI

1 reference

12 December 2020

Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring

1 reference

12 December 2020

Preservation of peripheral nerve function in severe uremia during treatment with low protein high calorie diet and surplus of essential amino acids

1 reference

12 December 2020

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

1 reference

12 December 2020

The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats

1 reference

12 December 2020

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

1 reference

12 December 2020

Sympathetic reflex latencies and conduction velocities in patients with polyneuropathy.

1 reference

12 December 2020

Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil

1 reference

12 December 2020

Method for quantitative estimation of thermal thresholds in patients

1 reference

12 December 2020

Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil

1 reference

12 December 2020

Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus

1 reference

12 December 2020

Variability of sensory threshold determination in clinical use

1 reference

12 December 2020

Nerve conduction velocity: relationship of skin, subcutaneous and intramuscular temperatures

1 reference

12 December 2020

Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

1 reference

12 December 2020

Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation

1 reference

12 December 2020

Improvement of peripheral nerve function after institution of insulin treatment in diabetes mellitus. A case-control study

1 reference

12 December 2020

Clinical trial of an aldose reductase inhibitor in diabetic neuropathy

1 reference

12 December 2020

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

12 December 2020

Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function

1 reference

12 December 2020

Late responses as aids to diagnosis in peripheral neuropathy

1 reference

12 December 2020

Has one diabetic complication been explained?

1 reference

12 December 2020

CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats

1 reference

12 December 2020

Diabetic autonomic neuropathy

1 reference

12 December 2020

Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00283137

1 reference

30 November 2017

1 reference